- Capital Cube•2 months ago
Click here to see latest analysisBioLargo, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of BioLargo, Inc. – Innospec Inc., Chemtura Corporation, Calgon Carbon Corporation and W. R. Grace & Co. (IOSP-US, CHMT-US, CCC-US and GRA-US) that have also reported for this period.HighlightsSummary numbers: […] (Read more...) The post BioLargo, Inc. :BLGO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 7, 2016 appeared first on CapitalCube.
- Capital Cube•4 months ago
Click here to see latest analysisBioLargo, Inc. reports financial results for the quarter ended December 31, 2015.HighlightsSummary numbers: Revenues of USD 0.05 million, Net Earnings of USD -1.25 million.Gross margins widened from 38.92% to 43.75% compared to the same period last year, operating (EBITDA) margins now -1,583.01% from -1,111.93%.Change in operating cash flow of -79.75% […] (Read more...) The post BioLargo, Inc. :BLGO-US: Earnings Analysis: Q4, 2015 By the Numbers appeared first on CapitalCube.
|52wk Range||0.31 - 0.48|
|Day's Range||0.39 - 0.42|
|Avg Vol (3m)||20,233|
As of 1:46 PM EDT. Market closed.